×
S&P 500   3,780.17 (-0.14%)
DOW   30,717.07 (-0.19%)
QQQ   277.82 (-0.88%)
AAPL   136.25 (-0.34%)
MSFT   255.69 (-0.44%)
META   155.84 (-3.36%)
GOOGL   2,144.19 (-1.61%)
AMZN   107.64 (+1.35%)
TSLA   670.81 (-0.39%)
NVDA   145.34 (-4.12%)
NIO   21.09 (-2.90%)
BABA   114.84 (+1.02%)
AMD   73.16 (-4.33%)
MU   52.24 (-5.50%)
CGC   2.78 (-2.46%)
T   20.95 (-0.05%)
GE   62.49 (-1.85%)
F   11.12 (-0.09%)
DIS   94.50 (+0.11%)
AMC   13.45 (-0.74%)
PFE   51.49 (-1.79%)
PYPL   69.90 (+0.09%)
NFLX   175.65 (+0.45%)
S&P 500   3,780.17 (-0.14%)
DOW   30,717.07 (-0.19%)
QQQ   277.82 (-0.88%)
AAPL   136.25 (-0.34%)
MSFT   255.69 (-0.44%)
META   155.84 (-3.36%)
GOOGL   2,144.19 (-1.61%)
AMZN   107.64 (+1.35%)
TSLA   670.81 (-0.39%)
NVDA   145.34 (-4.12%)
NIO   21.09 (-2.90%)
BABA   114.84 (+1.02%)
AMD   73.16 (-4.33%)
MU   52.24 (-5.50%)
CGC   2.78 (-2.46%)
T   20.95 (-0.05%)
GE   62.49 (-1.85%)
F   11.12 (-0.09%)
DIS   94.50 (+0.11%)
AMC   13.45 (-0.74%)
PFE   51.49 (-1.79%)
PYPL   69.90 (+0.09%)
NFLX   175.65 (+0.45%)
S&P 500   3,780.17 (-0.14%)
DOW   30,717.07 (-0.19%)
QQQ   277.82 (-0.88%)
AAPL   136.25 (-0.34%)
MSFT   255.69 (-0.44%)
META   155.84 (-3.36%)
GOOGL   2,144.19 (-1.61%)
AMZN   107.64 (+1.35%)
TSLA   670.81 (-0.39%)
NVDA   145.34 (-4.12%)
NIO   21.09 (-2.90%)
BABA   114.84 (+1.02%)
AMD   73.16 (-4.33%)
MU   52.24 (-5.50%)
CGC   2.78 (-2.46%)
T   20.95 (-0.05%)
GE   62.49 (-1.85%)
F   11.12 (-0.09%)
DIS   94.50 (+0.11%)
AMC   13.45 (-0.74%)
PFE   51.49 (-1.79%)
PYPL   69.90 (+0.09%)
NFLX   175.65 (+0.45%)
S&P 500   3,780.17 (-0.14%)
DOW   30,717.07 (-0.19%)
QQQ   277.82 (-0.88%)
AAPL   136.25 (-0.34%)
MSFT   255.69 (-0.44%)
META   155.84 (-3.36%)
GOOGL   2,144.19 (-1.61%)
AMZN   107.64 (+1.35%)
TSLA   670.81 (-0.39%)
NVDA   145.34 (-4.12%)
NIO   21.09 (-2.90%)
BABA   114.84 (+1.02%)
AMD   73.16 (-4.33%)
MU   52.24 (-5.50%)
CGC   2.78 (-2.46%)
T   20.95 (-0.05%)
GE   62.49 (-1.85%)
F   11.12 (-0.09%)
DIS   94.50 (+0.11%)
AMC   13.45 (-0.74%)
PFE   51.49 (-1.79%)
PYPL   69.90 (+0.09%)
NFLX   175.65 (+0.45%)
CVE:IOM

Assure Stock Forecast, Price & News

C$5.40
-0.45 (-7.69%)
(As of 01/31/2022)
Add
Compare
Today's Range
C$5.40
C$5.54
50-Day Range
C$5.40
C$5.40
52-Week Range
C$5.30
C$14.25
Volume
4,816 shs
Average Volume
2,316 shs
Market Capitalization
C$69.22 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive IOM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Assure and its competitors with MarketBeat's FREE daily newsletter.

IOM Stock Forecast (MarketRank)

Overall MarketRank

0.85 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Assure logo

About Assure (CVE:IOM)

Assure Holdings Corp., together with its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries to physicians. The company has operations in Louisiana, Michigan, Pennsylvania, Texas, Colorado, South Carolina, and Arizona, the United States. Assure Holdings Corp. is based in Denver, Colorado.

IOM Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
91
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$25.50 million
Cash Flow
C$0.08 per share
Book Value
C$2.05 per share

Miscellaneous

Free Float
N/A
Market Cap
C$69.22 million
Optionable
Not Optionable
Beta
N/A














Assure Frequently Asked Questions

How has Assure's stock performed in 2022?

Assure's stock was trading at C$6.34 at the beginning of 2022. Since then, IOM shares have decreased by 14.8% and is now trading at C$5.40.
View the best growth stocks for 2022 here
.

Who are Assure's key executives?

Assure's management team includes the following people:
  • Mr. John Allen Farlinger C.A., Exec. Chairman & CEO (Age 62, Pay $555.07k)
  • Mr. Preston Thomas Parsons, Founder & Director (Age 42, Pay $964.14k)
  • Mr. Trent J. Carman, Advisor (Age 60, Pay $266.52k)
  • Mr. John Price, VP of Fin. & CFO
  • Mr. Alex Rasmussen, Exec. VP of Operations
  • Mr. Jerod Powell, Chief Information Officer
  • Mr. Scott Kozak, Director of Investor & Media Relations
  • Mr. Craig Caviness, VP of Corp. Devel.
  • Mr. Paul Webster, VP of Strategy
  • Mr. Sean Blosser, VP of Revenue Cycle Management

What other stocks do shareholders of Assure own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Assure investors own include Ballard Power Systems (BLDP), Orocobre (ORL), Profound Medical (PRN), 155675 (BLD.TO) (BLD), M&G (MNG), Lithium Americas (LAC), Just Energy Group (JE), Intuitive Surgical (ISRG), Inovio Pharmaceuticals (INO) and IG Group (IGG).

What is Assure's stock symbol?

Assure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IOM."

How do I buy shares of Assure?

Shares of IOM and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Assure's stock price today?

One share of IOM stock can currently be purchased for approximately C$5.40.

How much money does Assure make?

Assure (CVE:IOM) has a market capitalization of C$69.22 million and generates C$25.50 million in revenue each year.

How many employees does Assure have?

Assure employs 91 workers across the globe.

How can I contact Assure?

The official website for Assure is www.assureneuromonitoring.com. The company can be reached via phone at 720-287-3093.

This page (CVE:IOM) was last updated on 7/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.